The Digitimer D185 is a sophisticated, multipulse cortical stimulator designed for human neurophysiological research and intraoperative monitoring. This system delivers high-voltage, precisely timed trains of constant current pulses via standard neurostimulating electrodes, making it particularly suited for motor cortex mapping, language mapping, and functional brain localization during neurosurgical procedures.
Used by neurophysiology departments worldwide, the D185 is built to meet the needs of clinicians and researchers seeking reliable cortical stimulation with fine control over pulse parameters, current intensity, and timing. It is typically paired with bipolar ball-tipped probes or strip/grid electrodes.
Certain surgical procedures, especially those involving the spinal cord or requiring temporary interruption of spinal blood flow - such as thoraco-abdominal aortic aneurysm repair - pose a significant risk of neurological injury. These risks include sensory deficits and, in severe cases, paraplegia, due to potential trauma, nerve stretching, or vascular occlusion during surgery. To mitigate these risks, real-time monitoring of spinal cord integrity has become a crucial part of intra-operative care.
Somatosensory evoked potential (SEP) monitoring is commonly used to assess the ascending sensory pathways. This involves stimulating peripheral nerves (typically at the wrist or ankle) and recording the resulting cortical responses. Changes in the SEP waveform can serve as an early warning of neural compromise, and the technique has played a pivotal role in preventing surgically induced neurological damage.
However, SEP monitoring is not without limitations:
To address these limitations, the D185 MultiPulse Stimulator from Digitimer was developed in collaboration with leading neurophysiologists. This system enables transcranial electrical stimulation of the motor cortex, eliciting motor evoked potentials (MEPs) recorded from limb muscles. Because MEPs reflect the function of the same neural pathways responsible for voluntary motor control, they provide a direct and reliable assessment of descending motor tract integrity.
MEP monitoring allows surgical teams to detect motor pathway compromise in real time, complementing or even surpassing SEP monitoring in certain contexts. Changes in MEP waveform morphology, latency, or amplitude can offer critical insight, enabling timely intervention and reducing the risk of postoperative motor deficits.
A large-scale clinical trial involving 1000 patients across two U.S. centers demonstrated that MEP monitoring:
These results led to FDA clearance of the D185, and MEP monitoring is now widely adopted in spinal, cardiovascular, and neurosurgical procedures worldwide.
Important Note: This product is for research applications only. Not a medical device as defined in Regulation (EU) 2017/745 (EU MDR), Swiss Medical Devices Ordinance (MedDO, SR 812.213), or FDA 21 CFR Part 860. Not designed or intended to be used for diagnosis, treatment of disease or any other medical purposes.